Abstract
Phospholipids form the backbone of neural membranes, providing fluidity and permeability. Two plasma membrane fractions, one from synaptosomes (SPM), the other glial and neuronal cell bodies (PM), were prepared from different regions of autopsied Alzheimer disease (AD) brains. Corresponding fractions were prepared from age-matched control brains. All fractions from AD brains showed significantly lower levels of ethanolamine glycerophospholipids and significantly higher levels of serine glycerophospholipids than the control brain. No differences were observed in phosphatidylcholine levels among these membranes. These results suggest that altered phospholipid composition of plasma membranes may be involved in the abnormal signal transduction and neurodegeneration in AD.
Similar content being viewed by others
References
Svennerholm, L., and Gottfries, C. G. 1994. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J. Neurochem. 62:1039–1047.
Crutcher, K. A., Anderton, B. H., Barger, S. W., Ohm, T. G., and Snow, A. D. 1993. Cellular and molecular pathology in Alzheimer's disease. Hippocampus 3:271–288.
Farooqui, A. A., Liss, L., and Horrocks, L. A. 1988. Neurochemical aspects of Alzheimer's disease: Involvement of membrane phospholipids. Metabolic Brain Dis. 3:19–35.
Katzman, R., and Saitoh, T. 1991. Advances in Alzheimer's disease. FASEB J. 5:278–286.
Farooqui, A. A., and Horrocks, L. A. 1985. Metabolic and functional aspects of neural membrane phospholipids. Pages 341–348, in Horrocks, L. A., Kanfer, J. N., and Porcellati, G. (eds.), Phospholipids in the Nervous System, Vol. II: Physiological Role. New York: Raven Press.
Farooqui, A. A., and Horrocks, L. A. 1991. Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders. Brain Res. Rev. 16:171–191.
Nitsch, R., Pittas, A., Blusztajn, J. K., Slack, B. E., Growdon, J. H., and Wurtman, R. J. 1991. Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer's disease. Ann. NY Acad. Sci. 640:110–113.
Bothmer, J., and Jolles, J. 1994. Phosphoinositide metabolism, aging and Alzheimer's disease. Biochim. Biophys. Acta 1225:111–124.
Farooqui, A. A., and Horrocks, L. A. 1994. Involvement of glutamate receptors, lipases and phospholipases in long-term potentiation and neurodegeneration. J. Neurosci. Res. 38:6–11.
Horrocks, L. A., Spanner, S., Mozzi, R., Fu, S. C., D'Amato, R. A., and Krakowka, S. 1978. Plasmalogenase is elevated in early demyelinating lesions. Adv. Exp. Med. Biol. 100:423–438.
Nitsch, R. M., Blusztajn, J. K., Pittas, A. G., Slack, B. E., Growdon, J. H., and Wurtman, R. J. 1992. Evidence for a membran defect in Alzheimer disease brain. Proc. Natl. Acad. Sci. USA. 89:1671–1675.
Stokes, C. E., and Hawthorne, J. N. 1987. Reduced phosphoinositide concentration in anterior temporal cortex of Alzheimer's diseased brains. J. Neurochem. 48:1018–1021.
Jellinger, K., Kienzl, E., Puchinger, L., and Stachelberger, H. 1993. Changes of phospholipids in Alzheimer's disease bram. Pages 315–323, in Corain, B., Iqbal, K., Nicolini, M., Winblad, B., Wisniewski, H., and Zatta, P. (eds.), Alzheimer's Disease: Advances in Clinical and Basic Research. Chichester: John Wiley & Sons Ltd.
Kienzl, E., Puchinger, L., Jellinger, K., Stachelberger, H., and Varmuza, K. 1993. Studies of phospholipid composition in Alzheimer's disease brain. Neurodegeneration 2:101–109.
Barany, M., Chang, Y. C., Arus, C., Rustan, T., and Frey, W. H. 1985. Increased glycerol-3-phosphorylcholine in post-mortem Alzheimer's brain [letter]. Lencet 1:517.
Pettegrew, J. W., Moossy, J., Withers, G., McKeag, D., and Panchalingam, K. 1988.31P Nuclear magnetic resonance study of the brain in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 47: 235–248.
Pettegrew, J. W., Panchalingam, K., Moosy, J., Martinez, J., Rao, G., and Boller, F. 1988. Correlation of phosphorus-31 magnetic resonance spectroscopy and morphology finding in Alzheimer's disease. Arch. Neurol. 45:1093–1096.
Pettegrew, J. W. 1989. Molecular insights into Alzheimer disease. Ann. NY Acad. Sci. 568:5–28.
Ellison, D. W., Beal, M. F., and Martin, J. B. 1987. Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Humtington's disease. Brain Res. 417:389–392.
Iwamoto, N., Kobayashi, K., and Kosaka, K. 1989. The formation of prostaglandins in the postmortem cerebral cortex of Alzheimertype dementia patients. J. Neurol. 236:80–84.
Subbarao, K. V., Richardson, J. S., and Ang, L. C. 1990. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J. Neurochem. 55:342–345.
Zubenko, G. S. 1986. Hippocampal membrane alteration in Alzheimer's disease. Brain Res. 385:115–211.
Ginsberg, L., Atack, J. R., Rapoport, S. I., and Gershfeld, N. L. 1993. Evidence for a membrane lipid defect in Alzheimer disease. Mol. Chem. Neuropathol. 19:37–46.
Ginsberg, L., Atack, J. R., Rapoport, S. I., and Gershfeld, N. L. 1993. Regional specificity of membrane instability in Alzheimer's disease brain. Brain Res. 615:355–357.
Bondareff, W. 1987. Changes in the brain in aging and Alzheimer's disease. Assessed by neuronal counts. Neurobiol. Aging. 8: 562–563.
Khachaturian, Z. S. 1985. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1097–1105.
Wisniewski, H. M., Rabe, A., Zigman, J., and Silverman, W. 1989. Neuropathological diagnosis of Alzheimer Disease. J. Neuropathol. Exp. Neurol. 48:606–609.
Strosznajder, J., Wikiel, H., Kelleher, J. A., and Sun, G. Y. 1986. Diacylglycerol kinase and lipase activities in rat brain subcellular fractions. Neurochem. Int. 8:213–221.
Farooqui, A. A., Liss, L., and Horrocks, L. A. 1990. Elevated activities of lipases and lysophospholipases in Alzheimer's disease. Dementia 1:208–214.
Dugan, L. L., Demediuk, P., Pendley, C. E., II, and Horrocks, L. A. 1986. Separation of phospholipids by HPLC: All major classes, including ethanolamine and choline plasmalogens, and most minor classes, including lysophosphatidylethanolamine. J. Chromatog. 378:317–327.
Rouser, G., Fleischer, S., and Yamamoto, A. 1970. Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5:494–496.
Farooqui, A. A., Farooqui, T., Yates, A. J., and Horrocks, L. A. 1988. Regulation of protein kinase C activity by various lipids. Neurochem. Res. 13:499–511.
Cole, G., Dobkins, K. R., Hansen, L. A., Terry, R. D., and Saitoh, T. 1988. Decreased levels of protein kinase C in Alzheimer brain. Brain Res. 452:165–170.
Allain, H., Belliard, S., De Certaines, J., Bentué-Ferrer, D., Bureau, M., and Lacroix, P. 1993. Potential biological targets for anti-Alzheimer drugs. Dementia 4:347–352.
Farooqui, A. A., Liss, L., and Horrocks, L. A. 1988. Stimulation of lipolytic enzymes in Alzheimer's disease. Ann. Neurol. 23:306–308.
Porcellati, G. 1983. Phospholipid metabolism in neural membranes. Pages 3–35,in Sun, G. Y., Bazan, N., Wu, J. Y., Porcellati, G., and Sun, A. Y. (eds.), Neural Membranes. New York: Humana Press.
Mozzi, R., and Horrocks, L. A. 1992. Serine incorporation into phosphatidylserine in hypoxic rat brain cortex. Mol. Chem. Neuropathol. 17:183–188.
Mozzi, R., Andreoli, V., and Horrocks, L. A. 1993. Phosphatidylserine synthesis in rat cerebral cortex: effects of hypoxia, hypocapnia and development. Mol. Cell. Biochem. 126:101–107.
Crook, T. H., Tinklenberg, J., Yesavage, J., Petrie, W., Nunzi, M. G., and massari, D. C. 1991. Effects of phosphatidylserine in ageassociated memory impairment. Neurology 41:644–649.
Amaducci, L., and Denes, F. 1989. Phosphatidylserine in the treatment of Alzheimer's disease: Results of a multicenter study. Pages 251–260,in Bazan, N. G., Horrocks, L. A., and Toffano, G. (eds.), Phospholipids in the Nervous System: Biochemical and Molecular Pathology. Padova: Liviana Press.
Delwaide, P. J., Maertens de Noordhout, A., de Pasqua, V., Ylieff, M., Gyselinck-Mambourg, A. M., and Hurlet, A. 1989. Effects of phosphatidylserine (BC-PS) on aged brain in normal subjects and senile demented patients. Pages 261–268,in Bazan, N. G., Horrocks, L. A., and Toffano, G. (eds.), Phospholipids in the Nervous System: Biochemical and Molecular Pathology, Padova: Liviana Press.
Casamenti, F., Mantovani, P., Amaducci, L., and Pepeu, G. 1979. Effect of phosphatidylserine on acetylcholine output from the cerebral cortex of the rat. J. Neurochem. 32:529–533.
Mazzari, S., and Battistella, A. 1980. Phosphatidylserine effects of dopamine release from striatum synaptosomes. Pages 569–570,in di Benedetta, C., Balåzs, R., Gombos, G., and Porcellati, G. (eds.), Multidisciplinary Approach to brain Development. Amsterdam: Elsevier/North-Holland Biomedical Press.
Cohen, S. A., and Müller, W. E. 1992. Age-related alterations of NMDA-receptor properties in the mouse forebrain: partial restoration by chronic phosphatidylserine treatment. Brain Res. 584: 174–180.
Giusto, N. M., and Bazan, N. G. 1973. High increment of triglycerols with ether linkages in the retina during anoxia. Biochem. Biophys. Res. Commun. 55:515–521.
Hoyer, S. 1992. Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases. Mol. Chem. Neuropathol. 16:207–224.
Author information
Authors and Affiliations
Additional information
Special issue dedicated to Dr. Leon S. Wolfe.
Rights and permissions
About this article
Cite this article
Wells, K., Farooqui, A.A., Liss, L. et al. Neural membrane phospholipids in alzheimer disease. Neurochem Res 20, 1329–1333 (1995). https://doi.org/10.1007/BF00992508
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00992508